Back
Trevi Therapeutics Stock Predictions
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
74
TRVI
Trevi Therapeutics
Last Price:
$6.67
Seasonality Move:
16.12%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the Founder That's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Trevi Therapeutics Stock Forecast
-
Over the next 52 weeks, Trevi Therapeutics has on average historically risen by 28.7% based on the past 5 years of stock performance.
-
Trevi Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Trevi Therapeutics Stock Undervalued?The current Trevi Therapeutics [TRVI] share price is $6.40. The Score for TRVI is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
-
TRVI is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Trevi Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Trevi Therapeutics has on average historically risen by 28.7% based on the past 5 years of stock performance.
Trevi Therapeutics Stock Rating
Buy
74
Trevi Therapeutics (TRVI)
is a Buy
Is Trevi Therapeutics overpriced?
-
Trevi Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Trevi Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
trevitherapeutics.com
52-Week Data
52-Week High:
7.39
52-Week Low:
2.30
Prediction Charts
Market Cap:
618.8M
Price in USD:
6.40
Volume:
1.2M
Beta:
0.73
Technical Analysis
SMA50:
4.60
SMA100:
3.95
SMA200:
3.44
52-Wk Change:
78.27%
Stock Predictions
-
Is Trevi Therapeutics stock public?Yes, Trevi Therapeutics is a publicly traded company.
-
What is the Trevi Therapeutics stock quote today?The Trevi Therapeutics stock price is 6.40 USD today.
-
How to buy Trevi Therapeutics stock online?You can buy Trevi Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-4 | 4.34 | 4.43 | 4.52 | 4.22 |
| Mar-5 | 4.56 | 4.39 | 4.59 | 4.24 |
| Mar-6 | 4.33 | 4.29 | 4.48 | 4.29 |
| Mar-7 | 4.29 | 4.30 | 4.55 | 4.24 |
| Mar-11 | 6.17 | 6.30 | 6.58 | 5.80 |
| Mar-12 | 6.30 | 6.30 | 6.49 | 5.98 |
| Mar-13 | 6.30 | 6.29 | 6.36 | 6.02 |
| Mar-14 | 6.29 | 6.75 | 6.78 | 6.28 |
| Mar-17 | 6.73 | 6.54 | 6.73 | 6.38 |
| Mar-18 | 6.70 | 6.56 | 7.14 | 6.40 |
| Mar-19 | 6.98 | 6.81 | 6.98 | 6.60 |
| Mar-20 | 6.75 | 6.61 | 6.79 | 6.60 |
| Mar-21 | 6.52 | 6.47 | 6.62 | 6.37 |
| Mar-24 | 6.33 | 6.40 | 6.52 | 6.22 |
Trevi Therapeutics Earnings
Trevi Therapeutics Earnings Report: Per Share Trevi Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Trevi Therapeutics Forecast Revenue Growth
Trevi Therapeutics Stock Analysis: Historical quarterly revenues per share for Trevi Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.04 per share.
* Trevi Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.